Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 2

Interventions

Specimen Handling 277Magnetic Resonance Spectroscopy 228pembrolizumab 227Carboplatin 177Biopsy 168Cisplatin 164Nivolumab 157Cyclophosphamide 143Paclitaxel 123Radiotherapy 122Gemcitabine 115Bevacizumab 94durvalumab 91Dexamethasone 87Rituximab 79Oxaliplatin 78venetoclax 73atezolizumab 72Docetaxel 69Capecitabine 69Fluorouracil 68Doxorubicin 67Etoposide 65Radiosurgery 62Ipilimumab 61Prednisone 60Cytarabine 60Radiation 59Lenalidomide 56Pemetrexed 55

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × saponin QA-21V1 × 90 days × Clear all
NCT06057948 2026-06-05

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
94 enrolled
CNS

Neuroblastoma

NCT04936529 2026-05-07

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
286 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡